Document is current

Any future updates will be listed below

The 5-HT1A receptor agonist buspirone improves esophageal motor function and symptoms in systemic sclerosis: a 4-week, open-label trial

Crossref DOI link: https://doi.org/10.1186/s13075-016-1094-y

Published Online: 2016-09-01

Published Print: 2016-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark